Visit the AHRP blog:
http://ahrp.blogspot.com
Clinical Trials: Risks
BBC News: Key Data 'Missing" in Catastrophic TGN1412 Drug Trial PDF Print E-mail
Friday, 13 October 2006
"UK regulators did not receive findings that might have warned them of damage TGN1412 could do." 
Read more...
 
UK Chanel 4 Investigates: The Drug Trial That Went Wrong_Critique NEJM Editorial PDF Print E-mail
Wednesday, 27 September 2006
“The Drug Trial That Went Wrong” is an investigative report by Chanel 4 (UK) about the circumstances surrounding the near fatal drug trial testing the safety of  TGN1412, a monoclonal antibody drug, conducted in March 2006 at London's Northwick Park Hospital. [1] http://news.bbc.co.uk/go/pr/fr/-/1/hi/health/5377226.stm  It airs momorrow.
Read more...
 
Volunteers at Risk_Editorial, NEJM Justifies Catastrophic TGN1412 Experiment PDF Print E-mail
Wednesday, 27 September 2006
"As long as we continue to manipulate biology in new ways, we probably cannot prevent all such events from occurring. We must do what we can to minimize risk, but the future health of the world population demands that we not let adverse events put an end to medical progress."
Read more...
 
On the Toxicity of Chemotherapy for Breast Cancer-the Need for Vigilance PDF Print E-mail
Sunday, 27 August 2006

A study published in The Journal of the National Cancer Institute, found that advanced chemotherapy put patients at far greater
risks of harm than adverse effect reports from clinical trial data reveal.

Read more...
 
Company Knew of the Catastrophic Risk--so did the British Medicines Authority PDF Print E-mail
Sunday, 09 April 2006
"Risks of anaphylaxis applies to all studies at PAREXEL, with drugs at every stage of development, and the staff are well trained in anticipation of this (unlikely) possibility.
Read more...
 
<< Start < Prev 1 2 Next > End >>

Results 1 - 9 of 10
(C) 2008 Alliance for Human Research Protection
CMS installation and website development by Anne Krauss

General Terms & Disclaimer:

This site is not a monologue of truth. It is a catalyst for public debate about medical research conduct. The reader is urged to confront officials to clarify issues mentioned herein. This site is designed strictly to provide information for critical, literary, academic an public usage. A qualified and trustworthy medical professional must be consulted regarding medical issues, treatments, diagnoses, etc.

Please read the General Terms and Conditions of this agreement entirely and carefully before accessing this web site. By accessing the site, you agree to be bound by the terms and conditions listed herein. [continue]